article thumbnail

Avrobio halts gene therapy research and considers a sale

Bio Pharma Dive

The decision to explore “strategic alternatives” comes about six weeks after the company sold its most advanced treatment to Novartis for nearly $90 million.

article thumbnail

Pfizer to deepen cost cuts as latest sales forecasts miss expectations

Bio Pharma Dive

The company is now expecting to save $4 billion by the end of 2024, with a majority of the spending cuts coming from drug research and development.

Sales 280
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Artificial Intelligence (AI) in Pharma Sales and Marketing

Pharma Mirror

AI research has been defined as the field of study of intelligent agents, which refers to any system that perceives its environment and takes actions that maximize its chance of achieving its goals. The post Artificial Intelligence (AI) in Pharma Sales and Marketing appeared first on Pharma Mirror Magazine. What is AI?

Sales 130
article thumbnail

Aurinia to cut research after sale process fails to find a buyer

Bio Pharma Dive

The Canadian lupus drug developer said it engaged more than 60 parties during its eight-month business review, but only one expressed interest before walking away.

Sales 131
article thumbnail

How Market Listening Can Help Drive Your Pharma Sales Funnel

Pharma Mirror

The pharmaceuticals industry is responsible for the research, development, production and of medications and generates over 1.25 The post How Market Listening Can Help Drive Your Pharma Sales Funnel appeared first on Pharma Mirror Magazine. trillion in revenue globally.

Sales 130
article thumbnail

Gene editing biotech Homology hits reset and seeks a sale

Bio Pharma Dive

The company will lay off 87% of its workforce and halt further research, including for a gene editing therapy to treat the rare disease PKU.

article thumbnail

Novavax cuts workforce by 25% as COVID vaccine sales fall

Bio Pharma Dive

The layoffs, which will affect hundreds of employees, are part of a major restructuring designed to reduce operational and research spending by as much as half.

Sales 171